These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 10174177)

  • 21. Successful contracting depends on optimal retail pricing.
    Shaul RL; Hamilton RP
    Healthc Financ Manage; 1999 Jan; 53(1):37-9. PubMed ID: 10339162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate regulation as a strategy for hospital cost control: evidence from the last decade.
    Sloan FA
    Milbank Mem Fund Q Health Soc; 1983; 61(2):195-221. PubMed ID: 6553766
    [No Abstract]   [Full Text] [Related]  

  • 23. Contracted payers: the latest challengers to hospital billed charges.
    Fedor F
    Healthc Financ Manage; 2005 May; 59(5):42-4. PubMed ID: 15938347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing in Maryland. Maryland's all-payer rate-control system enjoys the support of providers, payers and legislators as well as the public.
    Merson MR
    Health Manage Q; 1991; 13(1):24-8. PubMed ID: 10110252
    [No Abstract]   [Full Text] [Related]  

  • 25. From DRGs to deregulation: New Jersey takes the road less traveled.
    Berliner HS; Delgado S
    J Am Health Policy; 1993; 3(4):44-8. PubMed ID: 10127499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health care regulation and the economics of federal health care policies.
    Higgins CW; Bruhn JB
    Health Care Manage Rev; 1981; 6(4):41-7. PubMed ID: 7319807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of hospital regulatory programs on per capita costs, utilization, and capital investment.
    Ashby JL
    Inquiry; 1984; 21(1):45-59. PubMed ID: 6232216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital rate regulation and market incentives: contemporary approaches to cost containment.
    Rosko MD
    J Health Hum Resour Adm; 1986; 8(4):320-38. PubMed ID: 10277655
    [No Abstract]   [Full Text] [Related]  

  • 29. The antitrust perspective on health industry competition.
    Miller FH
    J Health Hum Resour Adm; 1989; 12(1):128-48. PubMed ID: 10296433
    [No Abstract]   [Full Text] [Related]  

  • 30. Hospitals must raise rates, make profits.
    Johnson DE
    Health Care Strateg Manage; 2002 Jun; 20(6):2-3. PubMed ID: 12080863
    [No Abstract]   [Full Text] [Related]  

  • 31. What kind of payment? A community hospital perspective.
    Hitt DH
    Rep Natl Forum Hosp Health Aff; 1992; ():65-9; discussion 69-70. PubMed ID: 10164963
    [No Abstract]   [Full Text] [Related]  

  • 32. Mass retreat: the demise of Massachusetts hospital rate regulation.
    McDonough JE
    J Am Health Policy; 1992; 2(5-S):40-4. PubMed ID: 10117911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital budget and rate setting in Colorado.
    Singleton BW
    Top Health Care Financ; 1979; 6(1):41-9. PubMed ID: 113908
    [No Abstract]   [Full Text] [Related]  

  • 34. Hospital financial condition under state rate regulatory programs.
    Cleverley WO
    Hosp Health Serv Adm; 1986; 31(2):135-47. PubMed ID: 10275562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Margin alert: time to revisit your outpatient strategy.
    Abramson SM; Tyler D
    Healthc Financ Manage; 2006 Apr; 60(4):106-8, 110, 112-3. PubMed ID: 16610436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Government as regulator.
    Correia E
    Bull N Y Acad Med; 1985; 61(1):90-7. PubMed ID: 3855678
    [No Abstract]   [Full Text] [Related]  

  • 37. Hitting the reset button. More states consider return to rate-setting.
    Selvam A
    Mod Healthc; 2011 Dec; 41(49):30-1. PubMed ID: 22250497
    [No Abstract]   [Full Text] [Related]  

  • 38. New York's "grouping up" phenomenon, while accelerated, is by no means unique.
    Southwick K
    Strateg Healthc Excell; 1997 Apr; 10(4):1-8. PubMed ID: 10166457
    [No Abstract]   [Full Text] [Related]  

  • 39. Marketplace. Kaiser beats a determined retreat from its market share strategy.
    Moskowitz DB
    Med Health; 1998 Apr; 52(16):suppl 1-2. PubMed ID: 10179402
    [No Abstract]   [Full Text] [Related]  

  • 40. Strengths and weaknesses of the Massachusetts model.
    Stowe JB
    Bus Health; 1984 Apr; 1(5):9-13. PubMed ID: 10273478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.